List of insiders holdings for Viking Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | LIGAND PHARMACEUTICALS INC 10% Owner | 2023-03-30 16:08:57 | 3,616,077 0 | 3,616,077 | Form 13D |
| 2 | Lian Brian President & CEO | 2026-01-05 20:28:24 | 2,675,591 0 | 2,675,591 | Form 4 |
| 3 | Dinerman Michael Chief Operating Officer | 2016-02-16 15:43:57 | 589,116 0 | 589,116 | Form 13G |
| 4 | Mancini Marianna Chief Operating Officer | 2026-01-05 20:31:16 | 500,190 0 | 500,190 | Form 4 |
| 5 | ZANTE GREG Chief Financial Officer | 2026-01-05 20:31:41 | 280,891 0 | 280,891 | Form 4 |
| 6 | Masamune Hiroko Chief Development Officer | 2019-01-03 20:33:20 | 207,063 0 | 207,063 | Form 4 |
| 7 | Aubuchon Neil William Chief Commercial Officer | 2026-01-26 19:57:19 | 180,000 0 | 180,000 | Form 4 |
| 8 | Hanley Rochelle Chief Medical Officer | 2016-05-05 17:36:38 | 160,836 0 | 160,836 | Form 4 |
| 9 | FOEHR MATTHEW W Director | 2026-01-05 20:25:28 | 155,586 0 | 155,586 | Form 4 |
| 10 | MORNEAU MICHAEL VP, Finance and Administration | 2021-01-19 18:21:31 | 116,062 0 | 116,062 | Form 4 |
| 11 | MACARTNEY LAWSON Director | 2026-01-05 20:26:27 | 71,515 0 | 71,515 | Form 4 |
| 12 | Rowland Charles A Jr Director | 2026-01-05 20:25:57 | 53,550 0 | 53,550 | Form 4 |
| 13 | SINGLETON J MATTHEW Director | 2026-01-05 20:26:57 | 33,050 0 | 33,050 | Form 4 |
| 14 | Rouan Sarah Kathryn Director | 2026-01-05 20:24:52 | 24,790 0 | 24,790 | Form 4 |
| 15 | Webster Stephen W Director | 2020-01-03 20:01:06 | 22,000 0 | 22,000 | Form 4 |